Health
Team reveals miR-29 as regulator of processes for normal brain maturation – Drug Target Review
Researchers have shown that miR-29 can control brain maturation in mammals, presenting a target for autism, epilepsy and other conditions.
Posted: 7 April 2021 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have shown that miR-29 can control brain maturation in mammals, presenting a target for autism, epilepsy and other conditions.
A team has discovered that a molecule called microRNA-29 (miR-29) is a powerful controller of brain maturation in mammals. The researchers, led by scientists at the University of North Carolina (UNC) School of Medicine, US, say that deleting miR-29 in mice caused problems very similar…
-
Business10 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General20 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News9 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business14 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?